Panacea Biotec receives CDR-EG approval for debt restructuring proposal

29 Sep 2014 Evaluate

Panacea Biotec has received CDR-EG approval for debt restructuring proposal. The Corporate Debt Restructuring Empowered Group (CDR-EG) had in its meeting held on September 09, 2014, approved Panacea Biotec’s Corporate Debt Restructuring (CDR) proposal which was referred to CDR Cell on December 21, 2013 and admitted by CDR -EG on January 24, 2014 and the LOA dated September 24, 2014 had been issued by CDR EG in this regard.

The necessary steps for implementation of the proposal shall be taken in due course of time in coordination with the Lenders.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

392.95 -14.10 (-3.46%)
29-Dec-2025 14:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1713.60
Dr. Reddys Lab 1266.00
Cipla 1495.00
Zydus Lifesciences 905.65
Lupin 2082.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×